산업동향
Recession-Resistant Medicine
- 등록일2008-12-24
- 조회수6276
- 분류산업동향 > 제품 > 바이오의약
-
자료발간일
2008-12-24
-
출처
Technology Review
- 원문링크
-
키워드
#Medicine
Recession-Resistant Medicine
Novel medical treatments thrive as investors get cautious.
By Larry Hardesty
In the third quarter of 2008, the first tremors of the financial crisis had been felt, and the number of venture deals in the U.S. fell to its lowest total since early 2005. According to Dow Jones's VentureWire, which tracks venture investment, information technology companies fared particularly badly, with their lowest deal total in more than 10 years.
But for the quarter, total dollars invested stayed fairly steady, off only about 1 percent from each of the first two quarters. So some companies were still getting big paydays. Of the 10 companies with the biggest third-quarter deals, the plurality--four--were in the health-care sector. One of those companies, Pacific Biosciences, builds genome-sequencing machines and figures prominently in Emily Singer's "Interpreting the Genome." The other three are testing promising new therapies for some of the most common medical conditions....계속
☞ 자세한 내용은 바로가기를 이용하시기 바랍니다.
관련정보
지식
동향
- 제도동향 [보건산업브리프 Vol. 393] 캘리포니아 재생 의학 연구소(California Institute for Regenerative Medicine, CIRM)의 펀딩의 이해 2024-02-06
- 산업동향 디지털 의료 (Digital Medicine) - 헬스케어의 경계를 확장하다 2018-10-24
- 산업동향 로슈(Roche)의 Foundation Medicine 인수 2018-07-26
- 정책동향 President Obama’s Precision Medicine Initiative 2015-02-03
- 제도동향 맞춤의학 : FDA’s Unique Role and Responsibilities in Personalized Medicine 2014-02-25